Metabolic Neuropathy Treatment in Lighthouse Point, FL

What it commonly feels like

• —Numbness and tingling in both feet with no diabetes diagnosis
• —Burning sensations alongside fatigue, cold intolerance or weight change
• —Symptoms that developed gradually over years rather than after an injury
• —Reduced sensation on monofilament or vibration testing at the feet
• —Muscle cramping and a general loss of strength in the legs

What drives it

• ✓Hypothyroidism or inadequately treated thyroid deficiency
• ✓Testosterone or estrogen deficiency
• ✓Insulin resistance and prediabetes short of a diabetes diagnosis
• ✓Chronic inflammatory metabolic state associated with obesity and metabolic syndrome

Nerve Damage Can Begin Before Diabetes Does

Impaired glucose tolerance and insulin resistance affect small sensory fibers before fasting glucose crosses the diabetic threshold. Patients in that window are frequently told their labs are fine while burning feet keep them awake. An A1c and a fasting insulin tell a more useful story than a single fasting glucose does. Identifying the metabolic driver at this stage is what makes the case more treatable than it will be in five years.

Thyroid and Sex Hormones Belong in a Neuropathy Workup

Hypothyroidism produces peripheral neuropathic symptoms through mechanisms unrelated to glucose, and it is common enough that it should be excluded in every case. Testosterone and estrogen deficiency contribute in a similar way. Where a deficiency is found and corrected, the driver itself is being addressed rather than the symptom it produces, which matters when the alternative is years of symptomatic medication. Contraindications and monitoring requirements are reviewed individually before anything is prescribed. This is why hormonal correction is a modality here and not an afterthought.

Correcting the Environment the Nerve Lives In

Hormonal correction addresses thyroid, testosterone or estrogen deficiency where testing identifies it as a contributing root cause. Metabolic optimization uses physician-prescribed semaglutide together with dietary guidance to reduce the inflammatory metabolic environment that drives progressive nerve damage. Peripheral neuropathy is not an FDA-approved indication for semaglutide; it is prescribed here for the metabolic driver rather than for the nerve itself. IV nerve-support infusions supply vitamin B12, alpha-lipoic acid and NAD+ directly into circulation, which matters because metabolic patients often have absorption limits that reduce what oral supplementation delivers. All of this is physician-supervised and matched to your results.

What Correction Does Not Fix

Normalizing a hormone or improving insulin sensitivity addresses the driver, which can slow further damage and gives surviving fibers a better environment. It does not regrow axons that have already degenerated. Patients who have carried an untreated metabolic driver for many years often have a mixed picture, with some function that responds and some that does not. Your baseline testing is what tells us where that line sits in your case.